Saidha, Shiv http://orcid.org/0000-0001-6387-0714
Bell, Judith http://orcid.org/0000-0002-9651-7463
Harold, Sydney http://orcid.org/0000-0003-4706-7010
Belisario, Jose Marcano http://orcid.org/0000-0002-3372-2996
Hawe, Emma http://orcid.org/0000-0001-7043-4646
Shao, Qiujun
Wyse, Kerri http://orcid.org/0000-0003-0048-7683
Maiese, Eric M.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 1 September 2022
Accepted: 21 December 2022
First Online: 17 January 2023
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Shiv Saidha is a Professor in the Department of Neurology at the Johns Hopkins University School of Medicine. Dr. Saidha engaged in this research as a private consultant or advisor and not in his capacity as a Johns Hopkins faculty member, and has been compensated for a consulting or advising service by Novartis in income/honorarium. Dr. Saidha has received consulting fees from Medical Logix for the development of CME programs in neurology and has served on scientific advisory boards for Novartis, Biogen, Genentech Corporation, TG therapeutics, and Bristol Myers Squibb. He has performed consulting for Novartis, Genentech Corporation, JuneBrain LLC, and Lapix therapeutics. He is the PI of investigator-initiated studies funded by Genentech Corporation, Novartis, and Biogen. He previously received support from the Race to Erase MS foundation. He has received equity compensation for consulting from JuneBrain LLC and Lapix therapeutics. He was also the site investigator of a trial sponsored by MedDay Pharmaceuticals and is the site investigator of a trial sponsored by Novartis. Eric Maiese, Kerri Wyse, and Qiujun Shao are employees of Novartis Pharmaceuticals Corporation. Judith Bell, Sydney Harold, Jose Marcano Belisario, and Emma Hawe are employees of RTI Health Solutions and worked as consultants to Novartis Pharmaceuticals Corporation.